CoChat

HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines

Koopman, L.A., Mulder, A., Corver, W.E., Anholts, J.D.H., Giphart, M.J., Claas, F.H.J., Fleuren, G.J. · 1998 · Tissue Antigens
Cited by 45

The DOI matches its Crossref record.

Abstract

Downregulation of HLA class I expression is a common event in tumor biology. Various underlying mechanisms have been defined in different tumors, but the knowledge of HLA loss mechanisms in cervical carcinoma is limited. To identify causalities for loss of surface expression, we performed a detailed investigation of HLA class I phenotypes and genotypes in 5 primary cervical tumors and on derivative cell lines. Protein expression on primary tissues and cell lines was evaluated by immunohisto‐chemistry and flow cytometry respectively, using a broad panel of allele‐specific monoclonal antibodies. Loss of expression was seen in 3 cases, comprising B15‐locus loss, B15‐allelic loss, and loss of an A74/B15 haplotype and an A24 allele of the other haplotype. Cytokine treatment induced re‐expression of the B15‐locus loss, suggesting a regulatory defect underlying lack of constitutive expression in this tumor. In contrast, molecular analyses at the DNA and/or RNA level showed that the other, non‐inducible, losses were associated with chromosomal HLA gene defects. Loss of heterozygos‐ity analysis was performed to confirm larger genomic deletions. This study shows that HLA gene defects by mutation or loss of heterozygosity as well as regulatory defects are involved in cervical carcinogenesis. The resulting changes in HLA expression may directly affect the efficacy of the immune response to these human papillomavirus‐related neoplasms. Heterogeneity in the underlying loss mechanisms may offer individual tumors various opportunities to escape immune surveillance, and may severely compromise T‐cell based therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-0039.1998.tb03005.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 45

Metadata

Authors
Koopman, L. A., Mulder, A., Corver, W. E., Anholts, J. D. H., Giphart, M. J., Claas, F. H. J., & Fleuren, G. J.
Venue
Tissue Antigens
Publisher
Wiley
Published
1998-06
Volume
51
Issue
6
Pages
623-636
ISSN
  • 0001-2815 (ISSN-L)
  • 1399-0039
OpenAlex
W1977495045
Cited by
45
References
0
FWCI
2.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines. https://app.cochat.ai/papers/10.1111/j.1399-0039.1998.tb03005.x
The paper
Koopman, L. A., Mulder, A., Corver, W. E., Anholts, J. D. H., Giphart, M. J., Claas, F. H. J., & Fleuren, G. J. (1998). HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines. Tissue Antigens. https://doi.org/10.1111/j.1399-0039.1998.tb03005.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.